Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Citius Pharmaceuticals, Inc. (CTXR) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.94M |
|
$-8.22M |
|
$0.79M |
|
$3.15M |
|
$12.96M |
|
$-9.02M |
|
$-0.11M |
|
$-9.13M |
|
$-9.13M |
|
$-9.39M |
|
$-9.39M |
|
$-9.39M |
|
$-9.39M |
|
$-9.02M |
|
$-8.46M |
|
21.50M |
|
21.50M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$37.95M |
|
-- |
|
$102.45M |
|
$140.39M |
|
$38.21M |
|
-- |
|
$8.72M |
|
$46.92M |
|
$93.47M |
|
$84.12M |
|
$93.47M |
|
22.38M |
|
| Cash Flow Statement Financials | |
$-13.01M |
|
$-4.40M |
|
$20.88M |
|
$4.25M |
|
$7.72M |
|
$3.47M |
|
$4.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.01 |
|
79.99% |
|
-228.68% |
|
-228.68% |
|
-- |
|
-231.48% |
|
-208.43% |
|
$-13.01M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.03 |
|
0.97 |
|
92.40 |
|
-10.05% |
|
-11.17% |
|
-6.69% |
|
-10.05% |
|
$4.18 |
|
$-0.61 |
|
$-0.61 |
|